🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

PSYCHOPATHY.COMP Program Among Male Prison Inmates With Psychopathy

RecruitingNAAges 19 Years - 30 YearsMaleUniversity of Coimbra
NCT07481253 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to learn whether PSYCHOPATHY.COMP, an individual compassion-focused, therapy-based intervention of 20 weekly sessions, can reduce psychopathy in prison inmates. Psychopathy is linked with the most severe and persistent forms of antisocial behavior. This trial will also learn whether the program improves emotional and behavioral regulation. The main questions are: * Does PSYCHOPATHY.COMP reduce psychopathy? * Does PSYCHOPATHY.COMP improve emotional and behavioral regulation? Researchers will compare PSYCHOPATHY.COMP with the usual individual case management support provided in prisons. Portuguese-speaking adult male prison inmates will be invited to participate. Those who consent to participate will be screened for inclusion (T0). A total of 200 eligible participants will take part. All participants will be invited to complete a baseline assessment (T

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion criteria: * male prison inmates, * Portuguese-speaking, * aged between 19 and 30 years * having at least one prior case in the juvenile justice system in which a judicial measure was applied, * with high levels of psychopathic traits (measured with the SRP-SF and LSRPS self-reported questionnaires) * with an Antisocial Personality Disorder (ASPD) diagnosis (measured with the SCID-II) Exclusion criteria: * suspected psychotic/autism spectrum disorders and/or cognitive impairments, * female, * sentence length inferior to 24 months since the start of the study.
💊

What it tests

  • PSYCHOPATHY.COMP
  • Treatment as Usual (TAU)
📍

Where

1 site
Prisons of the Direção-Geral de Reinserção e Serviços Prisionais (DGRSP)
Lisbon, Portugal
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy